Microdosing · Lower dose plan
Microdosing Tirzepatide
A lower dose plan of compounded tirzepatide, a dual GIP and GLP-1 medication that acts on two hormone pathways involved in appetite and food intake. It is a small injection you take once a week, prescribed by a licensed provider and shipped to your door if approved.
- 1, 3, 6 and 12 month plans
- Dose set and reviewed by a licensed provider
- Health coach check-ins included in every plan
- Shipped directly to your door
$199 / month
As low as $149 per 4 weeks with a 12 month plan
Choose your plan
- 1 monthBilled monthly$199per month
- 3 monthsPaid upfront$507$169 / month · Save $90
- 6 monthsPaid upfront$954$159 / month · Save $240
- 12 monthsPaid upfront$1,937$149 per 4 weeks · Save $650Best value
Free online assessment. No payment before provider approval.
What is microdosing?
Microdosing is a lower dose plan of compounded tirzepatide. Your licensed provider decides whether a lower dose is appropriate for you and sets your dose based on your health history and goals.
“Microdosing” is not a standardized FDA-approved dosing designation. A licensed provider determines eligibility and dosing.
How is it taken?
It is a small injection given just under the skin once a week, in the stomach, thigh, or upper arm. Your provider sets your dose.
How much does it cost?
$199 for 1 month. You can also prepay: $507 for 3 months ($169 per month), $954 for 6 months ($159 per month), or $1,937 for 12 months, which works out to $149 per 4 weeks. Each month is a 4 week supply.
No long term commitment, no membership fee, and you can cancel at any time. See full pricing.
What side effects should I expect?
The most common side effects are gastrointestinal, such as nausea or reduced appetite, and are usually mild to moderate. They tend to ease as your body adjusts, especially with gradual dosing. Your care team helps you manage them.
Read the Important Safety Information, including the boxed warning, before you start.
Who should not take it?
Do not use tirzepatide if you or a family member has had medullary thyroid carcinoma (MTC), if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have had a serious allergic reaction to it. Talk with your provider if you are pregnant, breastfeeding, or planning a pregnancy.
Prescription required. “Microdosing” is not a standardized FDA-approved dosing designation. A licensed provider determines eligibility and dosing. Compounded medications are not FDA-approved. Important Safety Information
